These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 25239303)

  • 21. Distinguishing characteristics of metabolically healthy versus metabolically unhealthy obese adolescent girls with polycystic ovary syndrome.
    Kim JY; Tfayli H; Michaliszyn SF; Lee S; Arslanian S
    Fertil Steril; 2016 Jun; 105(6):1603-11. PubMed ID: 26921624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes.
    Aziz M; Sidelmann JJ; Faber J; Wissing ML; Naver KV; Mikkelsen AL; Nilas L; Skouby SO
    Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1082-9. PubMed ID: 26123797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening women with polycystic ovary syndrome for metabolic syndrome.
    Dokras A; Bochner M; Hollinrake E; Markham S; Vanvoorhis B; Jagasia DH
    Obstet Gynecol; 2005 Jul; 106(1):131-7. PubMed ID: 15994628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters.
    Carmina E; Chu MC; Longo RA; Rini GB; Lobo RA
    J Clin Endocrinol Metab; 2005 May; 90(5):2545-9. PubMed ID: 15728203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome.
    Rossi B; Sukalich S; Droz J; Griffin A; Cook S; Blumkin A; Guzick DS; Hoeger KM
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4780-6. PubMed ID: 18812482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
    Panidis D; Tziomalos K; Macut D; Delkos D; Betsas G; Misichronis G; Katsikis I
    Fertil Steril; 2012 Feb; 97(2):494-500. PubMed ID: 22192350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria.
    Shroff R; Syrop CH; Davis W; Van Voorhis BJ; Dokras A
    Fertil Steril; 2007 Nov; 88(5):1389-95. PubMed ID: 17462641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subclinical hypothyroidism in young women with polycystic ovary syndrome: an analysis of clinical, hormonal, and metabolic parameters.
    Benetti-Pinto CL; Berini Piccolo VR; Garmes HM; Teatin Juliato CR
    Fertil Steril; 2013 Feb; 99(2):588-92. PubMed ID: 23103018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Lifestyle Intervention on Cardiometabolic Risk Factors in Overweight and Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
    Khatlani K; Njike V; Costales VC
    Metab Syndr Relat Disord; 2019 Dec; 17(10):473-485. PubMed ID: 31513475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?
    Chang AY; Wild RA
    Semin Reprod Med; 2009 Jul; 27(4):299-305. PubMed ID: 19530063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.
    Goverde AJ; van Koert AJ; Eijkemans MJ; Knauff EA; Westerveld HE; Fauser BC; Broekmans FJ
    Hum Reprod; 2009 Mar; 24(3):710-7. PubMed ID: 19095675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polycystic ovary syndrome and metabolic syndrome in Indigenous Australian women.
    Boyle JA; Cunningham J; Norman RJ; Dunbar T; O'Dea K
    Intern Med J; 2015 Dec; 45(12):1247-54. PubMed ID: 26387977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
    Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM; Ostapowicz G; Weltman MD
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
    Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
    J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: association between endocrine characteristics and metabolic aberrations.
    Huang CC; Tien YJ; Chen MJ; Chen CH; Ho HN; Yang YS
    Hum Reprod; 2015 Apr; 30(4):937-46. PubMed ID: 25662806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome in polycystic ovary syndrome.
    Carmina E
    Minerva Ginecol; 2006 Apr; 58(2):109-14. PubMed ID: 16582867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study.
    Schmidt J; Landin-Wilhelmsen K; Brännström M; Dahlgren E
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3794-803. PubMed ID: 21956415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
    Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
    Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic profile of the different phenotypes of polycystic ovary syndrome in two Latin American populations.
    Ladrón de Guevara A; Fux-Otta C; Crisosto N; Szafryk de Mereshian P; Echiburú B; Iraci G; Perez-Bravo F; Sir-Petermann T
    Fertil Steril; 2014 Jun; 101(6):1732-9.e1-2. PubMed ID: 24666752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.